CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory University School of ...

To date, there are no approved vaccines or antiviral treatments for human norovirus, the leading cause of acute gastroenteritis outbreaks worldwide with more than 685 million infections each year.

Subject enrollment expected to begin in Q1 2026 CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral ...

Norovirus is notoriously hard to kill. The CDC recommends washing your hands vigorously with soap. (Mike Kemp / Getty Images / Blend Images) A nasty, highly contagious virus is spreading across the ...

CDI‑988 is the first oral antiviral drug candidate being developed for prevention and treatment of norovirus infections Company to present Phase 1 data and updates from ongoing Phase 1b study ...

All products featured on Self are independently selected by Self editors. However, when you buy something through our retail links, Condé Nast may earn an affiliate commission. If there’s one thing ...

From classrooms to workplaces, a nasty stomach virus is circulating again, and North Texas doctors say they're bracing for more cases this month. The norovirus, often mistaken for the stomach flu, ...

Will the upcoming norovirus season be just as early and active as the past year? While the answer may be anyone’s guess right now, federal health officials recently warned that the dominant strain of ...

A nasty, highly contagious virus is spreading across the country ahead of the holiday season — and it’s not the flu or Covid. Norovirus, also called the “winter vomiting disease,” has been rising ...

Seaweed may be a popular food item, but it has certain properties that mean it could act as a shield within the human body, effectively blocking norovirus infection. To date, there are no approved ...